Ashutosh Tiwari

Title: Ashutosh Tiwari: Innovator in Biotechnology

Introduction

Ashutosh Tiwari is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. His work has the potential to impact the treatment of viral infections, specifically Hepatitis B.

Latest Patents

Ashutosh Tiwari holds a patent for a "Humanized high affinity recombinant antibody against Hepatitis B surface antigen." This invention relates to a high affinity recombinant humanized antibody fragment (scFv) that is specific for hepatitis B surface antigen. It features unique inter/intra chain bonding interactions due to 28 altered amino acid residues from the original mouse (5S) antibody and its chimeric Fab form. The fine-tuning of the vernier zone residue makes it closer to the human sequence without any structural constraints. This innovation represents a significant advancement in the development of therapeutic antibodies.

Career Highlights

Throughout his career, Ashutosh Tiwari has worked with esteemed organizations such as the Department of Biotechnology and the All India Institute of Medical Sciences. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Subrata Sinha and Navin Khanna. Their collaborative efforts have furthered advancements in biotechnology and have led to significant research outcomes.

Conclusion

Ashutosh Tiwari's contributions to biotechnology, particularly through his patent on a humanized antibody for Hepatitis B, highlight his role as an innovator in the field. His work continues to pave the way for advancements in medical treatments and showcases the importance of research in combating viral infections.